期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
DIC病人血浆中能被凝血酶激活的纤维溶解抑制因子的活性及抗原水平(原载:Thromb Res 2001 Oct 1;104(1):1—6)
1
《传染病网络动态》 2002年第1期16-16,共1页
关键词 弥温性血管内凝血 DIC 凝血酶 纤维溶解抑制因子 抗原水平
下载PDF
PAI-1反义寡核苷酸对肾间质细胞抑制作用的实验研究
2
作者 崔飞伦 邱镇 +2 位作者 陆洪兵 姚震 林大春 《解剖科学进展》 CAS 2008年第1期70-72,共3页
目的研究纤维蛋白溶解酶原激活物抑制因子-1(PAI-1)反义寡核苷酸(antisense oligonucleotides,ASODN)对大鼠肾间质细胞(NEK293)的抑制作用。方法采用RT-PCR、Western blot检测脂质体介导的PAI-1ASODN目的基因及蛋白的表达;通过细胞生长... 目的研究纤维蛋白溶解酶原激活物抑制因子-1(PAI-1)反义寡核苷酸(antisense oligonucleotides,ASODN)对大鼠肾间质细胞(NEK293)的抑制作用。方法采用RT-PCR、Western blot检测脂质体介导的PAI-1ASODN目的基因及蛋白的表达;通过细胞生长试验、流式细胞仪检测PAI-1 ASODN转染前后NEK293细胞增殖和凋亡的变化。结果PAI-1ASODN转染后可见NEK293中PAI-1mRNA及蛋白表达明显下调,与对照组相比较,可明显抑制细胞的增殖。诱导其凋亡(P<0.05)。结论PAI-1反义寡核苷酸具有明显抑制肾间质细胞增殖和诱导其凋亡的作用,转染脂质体介导的PAI-1 ASODN有望成为治疗肾纤维化的有效方法。 展开更多
关键词 纤维蛋白溶解酶原激活物抑制因子-1 反义寡核苷酸 肾间质细胞 增殖 凋亡
下载PDF
博莱霉素致肺纤维化大鼠模型的纤溶变化及低分子肝素的作用 被引量:4
3
作者 艾进颖 王红阳 +2 位作者 付爱双 刘信荣 喻昌利 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2009年第4期446-448,456,共4页
目的探讨博莱霉素诱导大鼠肺纤维化过程中纤溶变化与肺纤维化的关系,观察低分子肝素的作用并探讨其机制。方法75只Wistar大鼠分为低分子肝素(LMWH)组、强的松组、低分子肝素和强的松联合用药组、模型组、对照组。应用气管内灌注博莱霉... 目的探讨博莱霉素诱导大鼠肺纤维化过程中纤溶变化与肺纤维化的关系,观察低分子肝素的作用并探讨其机制。方法75只Wistar大鼠分为低分子肝素(LMWH)组、强的松组、低分子肝素和强的松联合用药组、模型组、对照组。应用气管内灌注博莱霉素A5制备大鼠肺纤维化模型,于第15天开始每天给药(低分子肝素或强的松或联合给药),第28、42、56天取肺组织行苏木精-伊红和Masson染色以观察其病理变化,免疫组织化学方法测定纤维蛋白溶解酶原激活物抑制因子-1(PAI-1)的表达,加钙法测定优球蛋白溶解时间(ELT)。结果模型组PAI-1表达明显升高、ELT延长(均P<0.05),肺纤维化严重,但PAI-1表达与时间无相关性;LMWH组PAI-1表达持续降低,较强的松组显著,ELT明显缩短(均P<0.05),肺纤维化程度减轻;联合用药组肺纤维化程度减轻、PAI-1表达降低、ELT明显缩短(均P<0.05)。结论大鼠肺纤维化出现PAI-1高表达、ELT延长,纤溶活性下降。而LMWH能减轻大鼠肺纤维化,与强的松联合应用效果更明显,可能与抑制PAI-1表达、缩短ELT,提高纤溶活性有关。 展开更多
关键词 肺纤维化 纤维蛋白溶解酶原激活物抑制因子-1 纤维蛋白溶解 低分子肝素
下载PDF
Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study
4
作者 LU Xing-guo WU Xian-guo +5 位作者 XU Xiao-hua GONG Xu-bo ZHOU Xuan XU Gen-bo ZHU Lei ZHAO Xiao-ying 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2007年第8期570-574,共5页
Objective: The purpose of this work was to investigate the distribution pattern of fibrinolytic factors and their inhibitors in rabbit tissues. Methods: The components of the fibrinolytic system in extracts from a var... Objective: The purpose of this work was to investigate the distribution pattern of fibrinolytic factors and their inhibitors in rabbit tissues. Methods: The components of the fibrinolytic system in extracts from a variety of rabbit tissues, including tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), plasminogen (Plg), plasmin (Pl) and α2 plasmin inhibitor (α2PI), were determined by colorimetric assay. Results: The tissue extracts in renal, small intestine, lung, brain and spleen demonstrated strong fibrinolytic function, in which high activity of tPA, Plg and Pl was manifested; whereas in skeletal muscle, tongue and stomach, higher activity of PAI-1 and α2PI showed obviously. Also excellent linear correlations were found between levels of tPA and PAI-1, Pl and α2PI, Plg and Pl. In related tissues, renal cortex and renal marrow showed distinctly higher activity of tPA and lower activity of PAI-1, with the levels of Plg and Pl in renal cortex being higher than those in renal marrow, where the α2PI level was higher than that in renal cortex. Similarly, the levels of tPA, Plg and Pl in small intestine were higher than those in large intestine, but with respect to PAI-1 and α2PI, the matter was reverse. In addition, the fibrinolytic activity in muscle tissue was lower, however, the levels of tPA, Plg, and Pl in cardiac muscle were obviously higher than those in skeletal muscles, and the levels of PAI-1 and α2PI were significantly lower than those in skeletal muscle. Conclusion: Our data demonstrate that a remarkable difference of the fibrinolytic patterns exists in rabbit tissues, which has probable profound significance in understanding the relationship between the function of haemostasis or thrombosis and the physiologic function in tissues. 展开更多
关键词 Tissue extract Fibrinolytic factors Fibrinolytic inhibitors
下载PDF
精浆中的抗补体分子 被引量:1
5
作者 程姝娟 郑振群 《国外医学(分子生物学分册)》 CSCD 1994年第6期269-272,共4页
人类精浆含有补体抑制因子,有较强的抗补体活性。其中的补体溶解抑制因子SP-40/40已得到重组制品,小鼠体内的硫化糖蛋白(SGP-2)和公羊体内的群集素(clusterin)与SP-40/40是不同种系的同源体,具有相似的特性和功能,因而三者统一命名为群... 人类精浆含有补体抑制因子,有较强的抗补体活性。其中的补体溶解抑制因子SP-40/40已得到重组制品,小鼠体内的硫化糖蛋白(SGP-2)和公羊体内的群集素(clusterin)与SP-40/40是不同种系的同源体,具有相似的特性和功能,因而三者统一命名为群集素。本文对这种具有抑制补体活性的群集素的近年研究进展加以介绍。 展开更多
关键词 精浆 群集素 补体 分子 溶解抑制因子
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部